You have 9 free searches left this month | for more free features.

Immunosuppression

Showing 1 - 25 of 2,595

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Torque Teno Virus: A Biomarker of Immunosuppression

Recruiting
  • Renal Transplant Rejection
  • +3 more
  • None Observational study
  • London, United Kingdom
    Royal London Hospital
Feb 23, 2023

Immune Response to Assess Immunosuppression After Liver

Not yet recruiting
  • Improve Allograft and Patient Outcomes in Solid Organ Transplantation by Using PPM to Develop Prospective Monitoring
    • (no location specified)
    Sep 26, 2023

    De Novo Metabolic Syndrome in Liver Transplant Patients After

    Completed
    • Single Transplant
    • 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
    • Rome, Italy
      Roberta Angelico
    Mar 29, 2023

    Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)

    Not yet recruiting
    • Renal Transplant Rejection
    • Renal Transplant Infection
    • (no location specified)
    Nov 1, 2022

    Immunosuppression Reduction in Failed Allograft Guided by cfDNA

    Recruiting
    • Kidney Transplant; Complications
    • +2 more
    • Blood Draw
    • Minneapolis, Minnesota
      University of Minnesota
    Oct 21, 2022

    Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)

    Not yet recruiting
    • Immune Tolerance
    • +2 more
    • Tacrolimus or Cyclosporine A
    • Tianjin, Tianjin, China
      Tianjin First Central Hospital
    Nov 23, 2023

    Evaluation of the Impact of Reduced Immunosuppression

    Enrolling by invitation
    • Graft Vs Host Disease
    • Dallas, Texas
      Methodist Dallas Medical Center
    Dec 20, 2022

    Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)

    Not yet recruiting
    • BK Viremia
    • +2 more
    • Immunosuppression reduction/modification + intravenous immunoglobulin
    • Immunosuppression reduction/modification
    • (no location specified)
    Oct 16, 2022

    COVID-19 Trial in Vienna (Immunosuppression reduction, No immunosuppression reduction)

    Active, not recruiting
    • COVID-19
    • Immunosuppression reduction
    • No immunosuppression reduction
    • Vienna, Austria
      Medical University of Vienna
    Apr 16, 2022

    Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant Trial in Gainesville (DOT intervention)

    Not yet recruiting
    • Heart Transplant Rejection
    • +3 more
    • DOT intervention
    • Gainesville, Florida
      University of Florida
    Feb 8, 2023

    Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,

    Recruiting
    • Kidney Transplant Recipients
    • Liver Transplant Recipients
    • Pfizer-BioNTech Bivalent COVID-19 Vaccine
    • +3 more
    • San Diego, California
    • +14 more
    Oct 31, 2022

    COVID-19, Immunosuppression, Vaccine Response Impaired Trial in Sacramento (Reduction in antimetabolite immunosuppression)

    Recruiting
    • COVID-19
    • +2 more
    • Reduction in antimetabolite immunosuppression
    • Sacramento, California
      University of California, Davis
    Feb 7, 2022

    Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

    Withdrawn
    • Metastatic Melanoma
    • +5 more
    • single arm
    • (no location specified)
    Dec 20, 2022

    Corticosteroids Induced Immunosuppression Using Monocyte Human

    Not yet recruiting
    • Immunosuppression
    • mHLA-DR
    • (no location specified)
    Jan 17, 2022

    Stroke-induced Immunodepression in Neurorehabilitation

    Completed
    • Stroke
    • +2 more
    • Neurorehabilitation
    • Pavia, Italy
      Headache Science & Neurorehabilitation Center
    Jun 1, 2023

    Myocarditis, Heart Failure, Endomyocardial Biopsy Trial in Warsaw (Prednisone, Azathioprine, Placebo Prednisone)

    Not yet recruiting
    • Myocarditis
    • +4 more
    • Warsaw, Poland
      First Department of Cardiology, Medical University of Warsaw
    Apr 26, 2022

    Lymphoma Trial in Stanford (rituximab)

    Completed
    • Lymphoma
    • rituximab
    • Stanford, California
      Stanford University Medical Center
    May 25, 2022

    Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)

    Terminated
    • Patients Receiving Mismatched Allogeneic HCT
    • immunosuppression
    • Mainz, Germany
    • +3 more
    Jun 29, 2022

    Quantifying Systemic Immunosuppression to Personalize Cancer

    Recruiting
    • Melanoma
    • +6 more
    • MDSC quantification
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Nov 11, 2022

    Kidney Transplant; Complications Trial in Saint Louis (Once daily immunosuppression regimen, Twice daily immunosuppression

    Recruiting
    • Kidney Transplant; Complications
    • Once daily immunosuppression regimen
    • Twice daily immunosuppression regimen
    • Saint Louis, Missouri
      Washington University
    Nov 12, 2021

    Anti-COVID-19 Humoral and Memory T Cell Responses in Various

    Active, not recruiting
    • Immune Response
    • blood collection
    • Paris, France
      Hôpital Robert Debré
    Sep 15, 2022

    Infection, Transplant;Failure,Kidney Trial in San Francisco (Mycophenolate Mofetil)

    Withdrawn
    • Infection
    • Transplant;Failure,Kidney
    • Mycophenolate Mofetil
    • San Francisco, California
      University of California, San Francisco
    May 2, 2022

    TRU-IMMUNO: Optimizing Liver Immunosuppression

    Not yet recruiting
    • Liver Transplant Rejection
    • Patients monitored with TruGraf and TRAC Liver testing
    • (no location specified)
    Apr 26, 2022

    Immune Dysregulation in Patients With COVID-19

    Recruiting
    • COVID-19
    • Immunosuppression
    • mid covid-19 patients
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jan 6, 2023

    TruGraf Liver Gene Expression Serial Test

    Not yet recruiting
    • Autoimmune Liver Disease
    • +3 more
    • TruGraf®
    • (no location specified)
    Sep 27, 2023